The 5th Inning | Citrini on Phase II of AI, Semis, Robotics, Healthcare, and Teradyne

In this episode of Monetary Matters, Jack Farley interviews Citrini about artificial intelligence and robotics. Citrini shares his insights on the current state of AI, highlighting the shift from easy gains in semiconductor investments to the need for a more nuanced approach focusing on the implementation and ROI of AI. He discusses the potential of robotics, particularly in industrial automation, and names Teradyne as a promising company in this space. Citrini also touches on wide band gap semiconductors, the cyclical nature of the semiconductor industry, and the potential threats to NVIDIA's dominance. The conversation extends to healthcare, GLP-1 drugs, and the second-order impacts of these drugs on aesthetics and other industries. Finally, they discuss the potential of AI in various sectors, including finance and data analysis, and the impact of tariffs on the market.